Comparative Pharmacology

Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

DEXTROSE 5% IN PLASTIC CONTAINER vs NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

DEXTROSE 5% IN PLASTIC CONTAINER

Intravenous Fluid

Category C

NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Intravenous Fluid/Electrolyte Solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Dextrose is a monosaccharide that provides a source of calories and fluid for parenteral nutrition. It increases blood glucose levels and is metabolized to carbon dioxide and water, providing energy. It also serves as a source of water for hydration.

Normosol-R and Dextrose 5% is a balanced electrolyte solution with dextrose. The dextrose provides caloric support and prevents ketosis. The electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain osmotic balance and acid-base homeostasis. Acetate and gluconate serve as bicarbonate precursors to correct acidosis.

Clinical Dosing

Intravenous infusion: 500-1000 mL as needed based on fluid and caloric requirements. Typical rate: 100-200 mL/hour for maintenance. Maximum infusion rate: 0.5-0.8 g/kg/hour.

Intravenous infusion; dose depends on fluid and electrolyte needs. Typical adult dose: 500-1000 mL over 1-4 hours, may repeat based on clinical status.

Direct Interaction

None Documented